iomeprol has been researched along with Abnormalities, Drug-Induced in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Intravenous daily dosing for 4 weeks showed that iomeprol was well tolerated at doses as high as the maximum dose anticipated for clinical use." | 1.29 | Toxicological safety assessment of iomeprol, a new X-ray contrast agent. ( de Haën, C; Luzzani, F; Morisetti, A; Tirone, P, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morisetti, A | 1 |
| Tirone, P | 1 |
| Luzzani, F | 1 |
| de Haën, C | 1 |
1 other study available for iomeprol and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Toxicological safety assessment of iomeprol, a new X-ray contrast agent.
Topics: Abnormalities, Drug-Induced; Animals; Antibody Formation; Antigens; Contrast Media; Dogs; Drug Toler | 1994 |